Tyratech Share Discussion Threads

[jxman] 10/3/2014 13:38

Just don't understand the lack of interest here! Should be trading at least 30p based on current news

[jxman] 10/3/2014 09:38

She's going to blow soon

[dassaco] 07/3/2014 11:43

I think you are right.
Long term hold in my opinion.

[jxman] 07/3/2014 11:14

Good move this will blow in the coming months with more press coverage

[dassaco] 07/3/2014 10:32

Topped up this morning.
Criseren now have 4% of the company.
Thats 4% less shares in the market.

[jxman] 07/3/2014 09:46

Buyers returning, news on the way? Amazon?

[jxman] 07/3/2014 09:02

Not long till we go live!

[jxman] 06/3/2014 16:44

Nice tick up

[casablanca4] 06/3/2014 12:49

>mdchand

Fair point!

[mdchand] 05/3/2014 21:23

Casa believe it or not, shares can go down as well as up and even go sideways.....

[casablanca4] 04/3/2014 12:40

Anbody know why there is no movement?

[jxman] 02/3/2014 08:00

Looking for a good week.

[deepvalueinvestor] 01/3/2014 08:55

Jxman, can you calm it down or I will have to filter you? It's good to see enthusiasm but.....

[zelder] 28/2/2014 22:22

jxman- The Cambridge-news article is very (very) old!!

[jxman] 28/2/2014 22:00

Cambridge post Friday 28th feb TyraTech starting to make its markScan the list of UK quoted stocks and there are numerous examples of the classic falling knife. However, there can be few cases to rival the share price demise as that of chemical company TyraTech Inc.Although based in the US, TyraTech is listed over here and, perhaps surprisingly, boasts the presence of Standard life and Legal & General among others as major shareholders.Currently at 32p, the company has somehow clawed itself back from the brink, having seen its share price collapse from close to £5 three years back.While much of the early excitement and momentum behind those heady days evaporated, there are now, nevertheless, signs of a company that is beginning to gain recognition across its field.Such pointers could be worth exploring further and perhaps suggest that TyraTech could now be an attractive, albeit speculative, punt.Although firmly cast in the chemical sector by being a developer and producer of pesticides, any alignment to the conventional producers can be quickly dismissed.This is because TyraTech's offerings are based on and derived from natural ingredients before being harnessed to target only invertebrate pests that attack crops as well as people and pets.This is good news from a number of angles, including effectiveness, but importantly safety, as the products are not harmful to humans or animals.Having secured its own patents on the technology, the company, which can be seen as an eco-tech pesticide producer, has established products derived from natural plant oils and which are subsequently formulated to attack and effectively destroy their targets.Although it has taken TyraTech longer than originally anticipated to make its mark, some notable deals suggest it could grab a piece of what is potentially a massive global market.The estimated worth of the combined pesticide market for domestic and agricultural customers is said to be worth a staggering $33bn.And here the company has already gained acceptance by being aligned to the world's largest pesticide player, Terminix. A deal is already in place whereby Terminix is marketing TyraTech's technology as SafeShield Natural, supplying customers across the US, Canada and Mexico. Set to run to at least 2017, it is complemented by another collaboration with the giant Kraft food company, where the latter is using TyraTech's technology within its exciting functional foods programme.These alliances, along with others such as Arysta Lifesciences and Natural Forces Inc., should help build up earnings momentum in the coming years.House broker Brewin Dolphin is forecasting profits for next year and has pencilled in £1.34m pre-tax, along with EPS of 2.5p.If TyraTech can achieve that and continue to attract further blue chip client interest, then the shares look worth a punt at current levels. Read more:

[jxman] 28/2/2014 21:48

Reade formerly chaired Merial, a £1.5?billion animal health company, which makes the pet flea product Frontline. Jactel, who was originally a vet, was chief marketing officer at Merial and helped make Frontline the most successful consumer brand in the world for pets. Top guys running this company !

[jxman] 28/2/2014 21:46

Get buying!!! This is going to be enormousIn the UK too, Reade and his chief executive, Bruno Jactel, are negotiating with several top retailers and deals should be announced within weeks. The global head lice market is worth more than £430?million a year and TyraTech should capture a significant percentage of it over the next five years. Lice have developed a resistance to many treatments, which can also have side effects, such as scalp irritation and headaches. As a natural product, Vamousse is safer and it has been approved by the US Food and Drug Administration, one of the toughest pharmaceutical watchdogs.But head lice treatment is just one weapon in TyraTech's armoury. The firm has also developed natural insect repellents for humans and animals, a market worth almost £1.5?billion a year globally.

[jxman] 28/2/2014 16:07

Get a poster in every primary school. Boom

[mdchand] 28/2/2014 11:12

Following quote taken from American Vanguard's recent quarterly report:-



'Our subsidiary, Envance, provides American Vanguard with participation in natural products for commercial, consumer and agricultural pest control markets. We continue to gain shelf space in large U.S. mass-market outlets for our Terminix pest control sprays. And our equity investment in the underlying natural pest-control technology has appreciated recently with the positive stock market reaction to the introduction of TyraTech's nonchemical head lice treatment, which will be available for sale at Walmart stores in the United States. We feel that this is a forward-thinking investment on our part that could pay off quite significantly in the future.'

[jxman] 28/2/2014 09:08

Tyr and tyru firming up. Don't be too long buying tyr take off soon

[somerset lad] 24/2/2014 14:24

Sidam,

I think you're right: it's an SEC rule, not something which TYR can change.

Last time around SIPPDeal and TD phoned or sent corporate actions asking whether holders wanted to convert.

As many posters have already explained, the value analysis is clear: TYRU should trade at a very small premium to TYR reflecting the fact that the unrestricted shares can be sold to a wider set of buyers.

The trading position is unclear (and an interesting subject for a business school thesis on the efficient market hypothesis): Lifeline Scientific also has an unrestricted ticker (LSIC) and a restricted one (LSI) but for long periods over the last year or so, LSI sold at a large premium (which has now reversed and over-shot).

[sidam] 24/2/2014 13:55

I am almost certain the the rules are US SEC under Regulation S. That says that shares subscribed for on a foreign exchange, and if held for at least one year, can be converted to shares that can be sold to US residents (=TYRU). Or can be treated as one if the company files a full US prospectus as it would need to if it went to NASDAQ.

Filing a US prospectus is quite expensive. It could happen long term, but in my view not yet. My bet is that this company will be taken over by a big player once the demand for its product is proven. However, it would have to be agreed as management and AMVAC have a very large interest.

[nobbygnome] 24/2/2014 13:35

>> casa

On a rereading, I could be wrong about the change from the one year rule. I think Sidam is suggesting this is a periodic offer whereas I assumed it was a change to the status quo. So I guess the shares have to be held for a year still.

Nobby